Welcome to Medications.com

AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of ... - PR Newswire (press release)

(3) AstraZeneca has investigated the use of SEROQUEL XR, an atypical antipsychotic, in the treatment of MDD, aiming to develop another potential treatment ...

http://sev.prnewswire.com/medical... | Posted: Fri Feb 29 09:03:28 -0500 2008




© 2002-2007, Skylabs Inc.  |  About Us  |  Disclaimer/Terms of Use  |  Advertise  |  Contact Us  |  Site Map  |  Developed by: W3matter.com | Sleep Apnea